Digital brain health start-up Neurotrack raises $6.5m to market cognitive assessment and intervention

By SharpBrains | February 1, 2016

Neu­ro­track rais­es $6.5M for cog­ni­tive assess­ment tool, man­age­ment pro­gram (Mobi­Health News): “Palo Alto-based Neu­ro­track, which has devel­oped an online cog­ni­tive assess­ment test, raised $6.5 mil­lion in a round led by Khosla Ven­tures with par­tic­i­pa­tion from Social Cap­i­tal, Founders Fund, AME Cloud Ven­tures, and iSeed Ventures. 

Read More

Cogniciti and Johnson & Johnson Innovation partner to improve cognitive screenings for early identification of dementia

By SharpBrains | September 16, 2015

Cog­nic­i­ti Announces Col­lab­o­ra­tion with John­son & John­son Inno­va­tion to Eval­u­ate Online Cog­ni­tive Screen­ing to Iden­ti­fy Indi­vid­u­als at Risk for Demen­tia (Bay­crest press release): “Cog­nic­i­ti Inc., the Toron­­to-based devel­op­er of a 20-minute online cog­ni­tive test for adults con­cerned about mem­o­ry changes, today announced a col­lab­o­ra­tion agree­ment with Janssen Phar­ma­ceu­ti­cals, Inc. to eval­u­ate online screen­ing strate­gies for…

Read More

Can better cognitive testing platforms accelerate pharma’s Alzheimer’s research and development efforts?

By SharpBrains | May 4, 2015

. Alzheimer’s cure behind the boom in brain sci­ence (Finan­cial Review): “Bio­gen is one of many mem­bers of big phar­ma seek­ing the block­buster drug which will inevitably be worth mul­ti­ple bil­lions of dol­lars. Big phar­ma in the US spends about $US5 bil­lion a year on Alzheimer’s research and devel­op­ment. Expo­nen­tial growth in the dis­ease over…

Read More